Investor Insight InMed is a pharmaceutical drug development company advancing proprietary small-molecule drugs in Alzheimer’s and ophthalmology, backed by a…
Defying the broader slump in energy prices, the cost of EU emissions trading is on an upward trajectory, having climbed…